Macquarie Group LTD Ardelyx, Inc. Transaction History
Macquarie Group LTD
- $90.3 Billion
- Q3 2024
A detailed history of Macquarie Group LTD transactions in Ardelyx, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 8,948,448 shares of ARDX stock, worth $43 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
8,948,448
Previous 6,900,675
29.67%
Holding current value
$43 Million
Previous $51.1 Million
20.57%
% of portfolio
0.07%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding ARDX
# of Institutions
218Shares Held
141MCall Options Held
1.08MPut Options Held
2M-
Janus Henderson Group PLC London, X021.5MShares$103 Million0.08% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$84.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$65.3 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$58.3 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA7.41MShares$35.6 Million0.9% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $742M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...